Stockreport

FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma [Yahoo! Finance]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF The therapy has been developed in collaboration with Legend Biotech Corporation LEGN. Carvykti is now approved to treat adult patients with relapsed/refractory (r/r) M [Read more]